In the literature, the reduction in its levels and signaling in cardiac tissue is reported as a strategy to attenuate fibrosis [34] and in the context of chronic obstructive pulmonary disease acting as a protector by reducing TGF-β1 activities [35]. The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.